The FinTech Hub
Source: Live Mint Budget 2025: Pharma stocks experienced a mixed trading session on Saturday following Finance Minister Nirmala Sitharaman’s declaration of exemptions from basic customs duty (BCD) for 36 essential medications. Additionally, six life-saving drugs will only incur a reduced duty rate. “I propose to add 36 lifesaving drugs and medicines to the list of…
Source: Live Mint Stocks of Indian pharma companies supplying antiretroviral (ARV) medicines used to treat HIV to African countries tumbled on Monday after a US government order halted all foreign aid funding, including its AIDS relief program. On January 25, the US State Department put into action an executive order from President Donald Trump halting…
Source: Live Mint The Indian pharma industry is likely to grow at 9-11% in FY26 (as per Crisil Report), led by price hike and new launches in domestic market and rise in export demand from regulated markets. The Government of India has introduced PLI scheme for pharma industry to promote Make-in-India, wherein ~18-20% of imported…
Source: Live Mint Market outlook: The Indian equity markets remained resilient for a major part of the calendar year (CY) 2024, despite challenges posed by sticky inflation, weaker-than-expected Q2FY25 earnings, general election outcomes, FII outflows, and geopolitical uncertainty. Despite these headwinds, India’s benchmark indices, the Nifty 50 and Sensex, delivered positive returns of 11.35% and…
Source: Live Mint Stock market today: Despite heightening geopolitical tensions, the Indian stock market made a strong recovery on Friday, November 29 as strong support from heavyweights such as Bharti Airtel, Reliance Industries, and ICICI Bank helped the frontline indices finish the last trading day of November in positive territory. The Nifty 50 ended the…
Source: Live Mint Indian stock market today: It was another quiet day for Indian markets as the initial rally in IT stocks, which powered the indices upward, was quickly offset by a sharp downturn in the financial pack, resulting in a flat close for both the Nifty 50 and Sensex. The Nifty 50 ended the…
Source: Business Standard 3 min read Last Updated : Sep 26 2024 | 1:40 PM IST Shares of healthcare service provider Krsnaa Diagnostics jumped 4.39 per cent to hit the day’s high of Rs 875.65 during intra-day deals on the BSE. The northward movement in the company’s stock follows the announcement of a strategic…
Source: Business Standard 4 min read Last Updated : Sep 16 2024 | 11:02 AM IST The Indian pharmaceutical giants are taking a halt in filing new drug applications, with new filings lowest in the past 19 years, says a latest report by Japanese brokerage firm, Nomura. However, this is not concerning the…
Source: Business Standard 4 min read Last Updated : Sep 10 2024 | 1:59 PM IST Shares of pharmaceutical companies as well as contract drug manufacturing companies (CDMOs) experienced significant gains in intraday trade on Tuesday, after a double dose of good news on the domestic as well US market front. On Monday the 54th…
Source: Business Standard 3 min read Last Updated : Sep 09 2024 | 3:45 PM IST Shares of Panacea Biotec were locked in upper circuit of 10 per cent at Rs 270.60 on the BSE in Monday’s intra-day trade amid heavy volumes in an otherwise weak broader market. In the past one month, the stock…
